Tensivask 5mg tablets
Ingredients in every tablet
Each package contains
|ATC Level 1||C - Cardiovascular system|
|ATC Level 2||C08 - Calcium Channel Blockers|
|ATC Level 3||C08C - Selective Calcium Channel Blockers with Mainly Vascular Effects|
18 TO 65 YEARS OLD
For both hypertension and angina, the usual initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient's response and severity. In majority of hypertensive patients with 5 mg/day, the dose may not necessarily be increased. For those who need higher dose, amlodipine can be increased to 7.5 mg/day with maximum dose of 10 mg/day.
The recommended dose for chronic stable or vasospastic angina is 5-10 mg, with the lower dose suggested in patients with hepatic insufficiency. No dose adjusment of amlodipine is required upon concomitant administration of thiazide diuretics, beta-blockers, and angiotensin-converting enzyme inhibitors.
0 TO 18 YEARS OLD
The use of amlodipine in children has not been established.
65 YEARS OLD AND ABOVE
Elderly individuals may be started on 2.5 mg once daily and this dose may be used when adding amlodipine to other antihypertensive therapy.
SMALL OR FRAGILE PATIENTS
Small or fragile patients may be started on 2.5 mg once daily and this dose may be used when adding amlodipine to other antihypertensive therapy.
PATIENTS WITH HEPATIC INSUFFICIENCY
Patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine to other antihypertensive therapy.
Amlodipine is indicated for treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta-adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor.
Amlodipine is indicated for the first-line treatment of myocardial ischemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature. Amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or adequate doses of beta-blockers.